Causaly Raises $60 Million in Series B Funding to Catalyze AI-powered Preclinical Discovery

The financing, led by ICONIQ Growth, enables Causaly to accelerate innovation and drive increased adoption of its category-leading AI platform to modernize scientific research.

0 min read
Written by
Andrew Taylor
  • Categories
  • News
Receive the latest newsletter directly to your inbox
open quotes
Knowledge is the lifeblood of research organizations, and we are committed to our mission to make it discoverable, working with our customers to make sense of their scientific data and apply insights to enable evidence-driven decisions.
close quotes
Yiannis Kiachopoulos, Co-founder and CEO of Causaly.

About Causaly

About ICONIQ Growth

About Index Ventures

Press Contacts

More on News